Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Proteostasis Therapeutics Inc (NASDAQ:PTI)

2.08
Delayed Data
As of Oct 16
 +0.01 / +0.48%
Today’s Change
1.71
Today|||52-Week Range
16.67
-83.03%
Year-to-Date
No recent news for Proteostasis Therapeutics Inc.

Today’s Trading

Previous close2.07
Today’s open2.13
Day’s range2.03 - 2.22
Volume121,936
Average volume (3 months)153,022
Market cap$52.0M
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)-68.91%
Earnings growth (this year)-25.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+94.43%
P/E ratioNM
Price/Sales27.43
Price/Book0.64

Competitors

 Today’s
change
Today’s
% change
CDNACareDx Inc+0.26+4.71%
MBOTMicrobot Medical Inc-0.09-6.98%
TROVTrovagene Inc-0.04-4.44%
ONCSOncoSec Medical Inc-0.11-8.40%
Data as of 4:00pm ET, 10/16/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$8.4M
Annual profit (last year)-$37.2M
Net profit margin-444.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Meenu Chhabra Karson
Chief Financial Officer &
Treasurer
Helen M. Boudreau
Corporate headquarters
Cambridge, Massachusetts

Forecasts